Predictive value of HbA1c for in-hospital adverse prognosis in COVID-19: a systematic review and meta-analysis

Clinical and laboratory predictors of adverse clinical course and death in COVID-19 patients urgently need to be identified. So far, the association between HbA1c and in-hospital mortality of COVID-19 remains a controversial issue. The aim of this study is to analyze predictive value of HbA1c for adverse prognosis in COVID-19.
Source: Primary Care Diabetes - Category: Primary Care Authors: Source Type: research